Literature DB >> 18795273

High serum concentrations of cyclosporin related to administration of tigecycline.

Anita N Stumpf, Christian Schmidt, Wolfgang Hiddemann, Armin Gerbitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18795273     DOI： 10.1007/s00228-008-0557-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting.

Authors:  Jonathan R Nebeker; Paul Barach; Matthew H Samore
Journal:  Ann Intern Med       Date:  2004-05-18       Impact factor: 25.391

2.  A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient.

Authors:  Domenico Capone; Giuseppe Palmiero; Antonio Gentile; Vincenzo Basile; Stefano Federico; Massimo Sabbatini; Maria Potenza; Anna Perfetti; Maria Pieri; Giovanni Tarantino
Journal:  Curr Drug Metab       Date:  2007-05       Impact factor: 3.731

Review 3.  The pharmacokinetic and pharmacodynamic profile of tigecycline.

Authors:  Alison K Meagher; Paul G Ambrose; Thaddeus H Grasela; Evelyn J Ellis-Grosse
Journal:  Clin Infect Dis       Date:  2005-09-01       Impact factor: 9.079

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  The immunosuppressive antagonism of low doses of FK506 and cyclosporine.

Authors:  A Vathsala; S Goto; N Yoshimura; S Stepkowski; T C Chou; B D Kahan
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

6.  Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent.

Authors:  S J Projan
Journal:  Pharmacotherapy       Date:  2000-09       Impact factor: 4.705

Review 7.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  Cyclosporine immunosuppression.

Authors:  D M Canafax; N L Ascher
Journal:  Clin Pharm       Date:  1983 Nov-Dec

Review 9.  Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.

Authors:  Michel Mourad; Pierre Wallemacq; Martine De Meyer; Jacques Malaise; Luc De Pauw; Djamila Chaïb Eddour; Eric Goffin; Jan Lerut; Vincent Haufroid
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

10.  Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.

Authors:  Matthew Hoffmann; William DeMaio; Ronald A Jordan; Rasmy Talaat; Dawn Harper; John Speth; JoAnn Scatina
Journal:  Drug Metab Dispos       Date:  2007-05-30       Impact factor: 3.922
View more
  2 in total

Review 1.  Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.

Authors:  Yun Cai; Rui Wang; Beibei Liang; Nan Bai; Youning Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

2.  Tigecycline and cyclosporine interaction-an interesting case of biliary-excreted drug enhancing the oral bioavailability of cyclosporine.

Authors:  Nuggehally R Srinivas
Journal:  Eur J Clin Pharmacol       Date:  2009-02-18       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.